Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | -5.33%6.34B | 1.45%4.81B | 3.36%3.28B | 9.59%2B | -2.79%6.7B | -13.06%4.74B | -15.12%3.17B | -20.86%1.82B | -8.39%6.89B | 13.68%5.45B |
Refunds of taxes and levies | 430.89%4.99M | 430.08%4.99M | 333.90%4.08M | ---- | -98.22%939.51K | -97.54%940.95K | -97.52%940.95K | -99.33%1.43K | 4,868.17%52.75M | 4,156.31%38.26M |
Cash received relating to other operating activities | 270.10%218.43M | 23.66%154.16M | 104.01%144.53M | -48.21%44.45M | -85.83%59.02M | -79.58%124.66M | -86.77%70.84M | 72.06%85.83M | 28.49%416.42M | 82.71%610.58M |
Cash inflows from operating activities | -2.86%6.57B | 2.10%4.97B | 5.66%3.43B | 6.99%2.04B | -8.17%6.76B | -20.24%4.87B | -24.74%3.25B | -18.90%1.91B | -6.20%7.36B | 18.90%6.1B |
Goods services cash paid | -16.50%2.31B | -16.61%1.8B | -4.93%1.35B | -3.08%904.04M | -16.98%2.76B | -23.05%2.16B | -32.73%1.42B | -37.11%932.75M | 11.90%3.33B | 88.50%2.8B |
Staff behalf paid | 7.31%683.87M | 7.10%488.44M | 10.07%328.93M | 15.72%163.68M | 7.31%637.26M | 10.87%456.05M | 10.43%298.82M | -8.43%141.44M | -7.67%593.86M | -12.76%411.32M |
All taxes paid | 6.66%680.82M | 9.63%576.54M | 18.71%448.7M | 0.29%174.01M | -5.22%638.29M | -6.35%525.91M | -14.15%377.98M | -28.21%173.52M | -3.66%673.44M | -1.61%561.59M |
Cash paid relating to other operating activities | 16.89%294.17M | -11.07%132.24M | -9.85%76.73M | 22.23%63.27M | 31.99%251.65M | 1.87%148.7M | -7.94%85.12M | -11.91%51.77M | 26.75%190.66M | -40.09%145.98M |
Cash outflows from operating activities | -7.56%3.97B | -8.88%3B | 1.04%2.2B | 0.43%1.31B | -10.36%4.29B | -16.18%3.29B | -25.12%2.18B | -32.95%1.3B | 7.15%4.79B | 41.45%3.92B |
Net cash flows from operating activities | 5.30%2.6B | 24.97%1.97B | 15.06%1.23B | 21.02%735.63M | -4.11%2.47B | -27.56%1.58B | -23.95%1.07B | 46.95%607.85M | -23.84%2.58B | -7.62%2.18B |
Investing cash flow | ||||||||||
Cash received from disposal of investments | 95.04%1.22B | 238.91%1.09B | 277.13%961.79M | 272.83%869.05M | -56.87%624.23M | -62.19%320.68M | -62.23%255.03M | -60.87%233.1M | 17.20%1.45B | 34.04%848.11M |
Cash received from returns on investments | 12.14%43.59M | 221.89%45.8M | 290.30%43.76M | 2,199.47%35.62M | 16.45%38.87M | 10.99%14.23M | 108.90%11.21M | 360.65%1.55M | 155.49%33.38M | 107.79%12.82M |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -78.89%3.26M | -97.95%288.96K | -98.13%263.91K | -98.36%230.01K | 570.62%15.44M | 702.74%14.09M | 2,201.57%14.09M | 2,198.19%14.06M | -79.43%2.3M | -79.83%1.75M |
Cash received relating to other investing activities | -42.61%12.6M | ---- | ---- | ---- | -87.04%21.96M | ---- | ---- | ---- | --169.45M | ---- |
Cash inflows from investing activities | 82.29%1.28B | 224.61%1.13B | 258.80%1.01B | 263.83%904.89M | -57.61%700.5M | -59.55%348.99M | -58.85%280.33M | -58.32%248.71M | 31.23%1.65B | 33.21%862.69M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 5.20%2.43B | 26.59%1.5B | 55.21%1B | 71.56%612.5M | 119.49%2.31B | 115.53%1.19B | 222.96%646.76M | 212.71%357.02M | 96.17%1.05B | 86.62%550.47M |
Cash paid to acquire investments | 131.58%1.03B | 1,034.40%769.59M | 1,308.21%659.62M | 68.24%43.25M | -73.50%443.95M | -94.53%67.84M | -79.19%46.84M | -85.91%25.71M | 17.85%1.68B | 42.48%1.24B |
Cash paid relating to other investing activities | 51.52%47.73M | 36.81%45.9M | 57.12%44.7M | 274.06%44.7M | --31.5M | --33.55M | --28.45M | --11.95M | ---- | ---- |
Cash outflows from investing activities | 25.89%3.5B | 79.95%2.32B | 136.57%1.71B | 77.48%700.45M | 2.05%2.78B | -28.09%1.29B | 69.77%722.05M | 33.02%394.67M | 39.29%2.73B | 53.65%1.79B |
Net cash flows from investing activities | -6.91%-2.23B | -26.17%-1.18B | -59.00%-702.32M | 240.06%204.44M | -93.92%-2.08B | -1.14%-938.84M | -272.62%-441.72M | -148.65%-145.96M | -53.83%-1.07B | -79.20%-928.22M |
Financing cash flow | ||||||||||
Cash received from capital contributions | --58.61M | --58.61M | ---- | ---- | ---- | ---- | ---- | ---- | -15.13%10.94M | --10.94M |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | --58.61M | --58.61M | ---- | ---- | ---- | ---- | ---- | ---- | -15.13%10.94M | --10.94M |
Cash from bonds issue | 11.29%6.9B | 25.45%6.9B | -6.06%3.1B | -54.55%1.5B | 210.00%6.2B | 175.00%5.5B | 120.00%3.3B | 120.00%3.3B | -62.24%2B | -56.52%2B |
Cash from borrowing | 15.85%3.04B | 27.15%2.36B | -52.36%352.06M | -37.94%326.28M | 540.28%2.63B | 352.93%1.86B | 80.24%738.99M | 69.60%525.76M | 330.45%410M | 330.45%410M |
Cash inflows from financing activities | 13.31%10B | 26.68%9.32B | -14.53%3.45B | -52.26%1.83B | 264.53%8.83B | 203.89%7.36B | 110.34%4.04B | 110.77%3.83B | -55.21%2.42B | -48.44%2.42B |
Borrowing repayment | 18.73%9.22B | 31.72%8.94B | 3.49%3.56B | -0.65%1.54B | 86.41%7.77B | 96.99%6.78B | 80.75%3.44B | 32.39%1.55B | -37.31%4.17B | -35.43%3.44B |
Dividend interest payment | -0.70%749.4M | -1.06%783.16M | -49.33%138.7M | -54.69%40.22M | -2.29%754.66M | -0.20%791.58M | -0.61%273.73M | -39.54%88.78M | -28.99%772.32M | -25.13%793.14M |
-Including:Cash payments for dividends or profit to minority shareholders | -16.84%50.28M | -16.84%50.28M | -17.30%50M | ---- | 12.17%60.46M | 12.17%60.46M | 12.17%60.46M | ---- | -56.51%53.9M | -48.14%53.9M |
Cash payments relating to other financing activities | -16.59%66.55M | -47.72%4.67M | -32.95%3.14M | -39.38%2.2M | 13.28%79.78M | -16.57%8.94M | -33.16%4.69M | -30.98%3.62M | 15.72%70.43M | -41.50%10.72M |
Cash outflows from financing activities | 16.70%10.04B | 28.20%9.72B | -0.44%3.7B | -3.65%1.58B | 71.71%8.6B | 78.56%7.58B | 70.14%3.72B | 24.15%1.64B | -35.74%5.01B | -33.74%4.25B |
Net cash flows from financing activities | -117.76%-39.53M | -77.45%-403.95M | -178.63%-251.16M | -88.83%243.86M | 108.60%222.56M | 87.54%-227.64M | 220.08%319.4M | 343.58%2.18B | -8.28%-2.59B | -6.46%-1.83B |
Net cash flow | ||||||||||
Net increase in cash and cash equivalents | -45.09%335.14M | -6.71%384.96M | -70.81%276.32M | -55.24%1.18B | 156.13%610.28M | 171.76%412.64M | -32.17%946.52M | 119.37%2.65B | -471.84%-1.09B | -556.88%-575.01M |
Add:Begin period cash and cash equivalents | 36.11%2.3B | 36.11%2.3B | 36.11%2.3B | 36.11%2.3B | -39.15%1.69B | -39.15%1.69B | -39.15%1.69B | -39.15%1.69B | 11.77%2.78B | 11.77%2.78B |
End period cash equivalent | 14.57%2.64B | 27.71%2.69B | -2.27%2.58B | -19.63%3.48B | 36.11%2.3B | -4.52%2.1B | -36.81%2.64B | 8.84%4.34B | -39.15%1.69B | -15.65%2.2B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.